Decoy Therapeutics Inc.

DCOY · Moat type: REGULIERUNG

MoatScore

1/10

Fair Value

n/a

Margin of Safety

n/a

Rating

MEIDEN

Decoy Therapeutics Inc. is a preclinical to clinical biotechnology company that develops therapeutic proteins (so-called "decoy" receptors) for the treatment of inflammation and oncology indications, relying exclusively on licensing and milestone payments as potential future revenue sources.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.